Hepatobiliary Cancers
Combined hepatocellular-cholangiocarcinoma and rare hepatobiliary tumours
Clinical FeaturesClick to collapse
Typical Presentation
Source text not provided; cannot extract typical presentation.
InvestigationsClick to collapse
StagingClick to collapse
Source text not provided; cannot extract staging system.
Management PrinciplesClick to collapse
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Hepatobiliary Cancers have been separated into two distinct guidelines: the NCCN Guidelines for Hepatocellular Carcinoma and the NCCN Guidelines for Biliary Tract Cancers. The source text provided does not contain additional clinical details, treatment philosophy, or multimodal approach content.
No content provided.
No content provided.
Management PathwaysClick to collapse
SurgeryClick to collapse
No content provided.
Radiation TherapyClick to collapse
No content provided.
Systemic TherapyClick to collapse
No content provided.
Treatment Response AssessmentClick to collapse
Title
No content provided.
Timing
No content provided.
Hcc DefinitionClick to collapse
The provided source text only indicates that the NCCN Guidelines for Hepatobiliary Cancers are separated into the NCCN Guidelines for Hepatocellular Carcinoma and the NCCN Guidelines for Biliary Tract Cancers. No further definition, embryological origin, or anatomical boundaries are explicitly stated. Therefore, a comprehensive definition cannot be extracted from the given source.
Btc DefinitionClick to collapse
The provided source text only indicates that the NCCN Guidelines for Hepatobiliary Cancers are separated into the NCCN Guidelines for Hepatocellular Carcinoma and the NCCN Guidelines for Biliary Tract Cancers. No further definition, anatomical boundaries, or subsites (e.g., intrahepatic, perihilar, distal cholangiocarcinoma, gallbladder carcinoma) are explicitly stated. Therefore, a comprehensive definition cannot be extracted from the given source.
Hcc SubtypesClick to collapse
The provided source text does not contain any information on histologic or molecular subtypes of hepatocellular carcinoma. No names, frequencies, or key associations are mentioned. Therefore, subtypes cannot be extracted.
Btc SubtypesClick to collapse
The provided source text does not contain any information on histologic or molecular subtypes of biliary tract cancers. No names, frequencies, or key associations are mentioned. Therefore, subtypes cannot be extracted.
Hcc Molecular PathogenesisClick to collapse
The provided source text does not contain any information on genomic events, driver mutations, signaling pathways, or chromosomal abnormalities in hepatocellular carcinoma. No gene names or frequencies are mentioned. Therefore, molecular pathogenesis data cannot be extracted.
Btc Molecular PathogenesisClick to collapse
The provided source text does not contain any information on genomic events, driver mutations, signaling pathways, or chromosomal abnormalities in biliary tract cancers. No gene names or frequencies are mentioned. Therefore, molecular pathogenesis data cannot be extracted.
Hcc EpidemiologyClick to collapse
The provided source text does not contain any information on incidence, mortality, trends, demographics, or SEER/GLOBOCAN numbers for hepatocellular carcinoma. Therefore, epidemiology data cannot be extracted.
Btc EpidemiologyClick to collapse
The provided source text does not contain any information on incidence, mortality, trends, demographics, or SEER/GLOBOCAN numbers for biliary tract cancers. Therefore, epidemiology data cannot be extracted.
Hcc Risk FactorsClick to collapse
The provided source text does not contain any information on risk factors for hepatocellular carcinoma. No factors, types, details, or strength of evidence are mentioned. Therefore, risk factors cannot be extracted.
Btc Risk FactorsClick to collapse
The provided source text does not contain any information on risk factors for biliary tract cancers. No factors, types, details, or strength of evidence are mentioned. Therefore, risk factors cannot be extracted.
Hcc Protective FactorsClick to collapse
The provided source text does not contain any information on protective factors for hepatocellular carcinoma. Therefore, no protective factors can be extracted.
Btc Protective FactorsClick to collapse
The provided source text does not contain any information on protective factors for biliary tract cancers. Therefore, no protective factors can be extracted.
ErrorClick to collapse
The source text provided is only a header—'NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) The NCCN Guidelines for Hepatobiliary Cancers has been separated into the: NCCN Guidelines for Hepatocellular Carcinoma NCCN Guidelines for Biliary Tract Cancers NCCN.org'—which lacks all clinical content (staging, survival, treatment, trials, references, etc.). Without the full document text, I cannot extract the requested sections (prognosis, complications, supportive care, follow-up, surveillance, special situations, clinical pearls, guidelines resources, key trials, references) in a clinically accurate, non-hallucinated manner. Please provide the complete source document (e.g., full NCCN guideline PDF text) so I can produce the comprehensive handbook as specified.